APA (7th ed.) Citation

Fukuhara, K., Neelakantan, S., Furihata, K., Yuasa, H., Shi, N., Yamamoto, Y., & Hung, K. E. Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study. Wiley.

Chicago Style (17th ed.) Citation

Fukuhara, Kei, Srividya Neelakantan, Kenichi Furihata, Hirotoshi Yuasa, Nanzhi Shi, Yuichi Yamamoto, and Kenneth E. Hung. Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study. Wiley.

MLA (9th ed.) Citation

Fukuhara, Kei, et al. Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study. Wiley.